Detalhe da pesquisa
1.
Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy.
J Virol
; 88(10): 5242-55, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574403
2.
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Clin Transl Immunology
; 11(5): e1392, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573979
3.
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-ßGal and MVA-MUC1 (TG4010) in a murine tumor model.
Hum Vaccin Immunother
; 14(1): 140-145, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28925793
4.
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
Vaccine
; 35(4): 577-585, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28012777
5.
Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes.
Exp Cell Res
; 297(2): 363-79, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15212940